ArticlePloS one2025

Combining CD3/GD2 bispecific T cell engager with human Vγ9Vδ2 T cells facilitates neuroblastoma cell targeting and killing in vitro.

Kuntida Kitidee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.